| Name | Title | Contact Details |
|---|
Our mission as an organization is to serve our neighbors as expert, caring partners in their health. We do this by creating innovative, effective, affordable systems of care that our neighbors value. This is our promise to you. We call it The ChristianaCare Way. ChristianaCare has the most advanced health care technology available to help meet your needs. But more important than the technology is our commitment to partner with you to meet your individual needs. We want to care for you and help you live the healthy life you want to live.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Harborview Health Care is a Morehead City, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vision Events is a Bedford, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Intervet/ Schering-Plough Animal Health is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.